B. Riley lowered the firm’s price target on Lantheus (LNTH) to $122 from $127 and keeps a Buy rating on the shares. Competitor Telix’s (TLX) ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

In a regulatory filing, Lantheus ( LNTH) Holdings CFO Robert Marshall Jr. disclosed the sale of 10,000 common shares of the company on March 17 at a price of $100.52 per share. Discover stocks' market ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...

Raymond James Financial Inc. acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the fourth ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Lantheus Holdings, Inc.'s stock has surged 55% since my last “Buy” rating, driven by strong revenue growth from Pylarify and Definity, and a profitable business model. Strategic acquisitions ...

Lantheus Holdings, Inc. (NASDAQ:LNTH), a $6.83 billion market cap leader in the development and commercialization of innovative diagnostic and therapeutic agents, has been the subject of intense ...

Investors considering a purchase of Lantheus Holdings Inc (Symbol: LNTH) stock, but tentative about paying the going market price of $102.17/share, might benefit from considering selling puts ...

Lantheus had a net margin of 28.57% and a return on equity of 44.29%. The firm had revenue of $391.11 million for the quarter, compared to analysts’ expectations of $376.61 million.

Lantheus Holdings, Inc. (NASDAQ:LNTH), a $6.83 billion market cap leader in the development and commercialization of innovative diagnostic and therapeutic agents, has been the subject of intense ...